Organon & Co. Executive Compensation
Organon & Co. is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Organon & Co. discloses FY2025 compensation for 7 named executive officers, totaling $6.9M. Kevin Ali, the Executive Officer, accounts for 47% of that combined total.
Cash compensation (salary plus bonus) made up 71% of Organon & Co.'s FY2025 tracked executive pay, with stock awards accounting for 0%.
Among 78 other Healthcare companies in this dataset, Organon & Co.'s combined tracked executive pay of $6.9M ranks in the 36th percentile (industry median: $13.6M). Its highest-paid executive, Kevin Ali, ranks in the 28th percentile for top-executive pay in the sector (industry median: $6.3M).